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1. Introduction 
 
1.1. Research Background 
The nervous system is extremely complex. It is widely accepted that the adult mammalian 
central nervous system (CNS) is unable to regenerate axons. Traumatic injury to the adult 
mammalian CNS permanently interrupts neural pathways, resulting in irreversible 
functional deficits [164]. Damage to the optic nerve leads to visual impairment and to 
irreversible blindness of the affected eye in severe cases. During the last two decades, 
research experimental strategies have been developed to facilitate axonal regeneration and 
restore interrupted neural connections between the eye and the brain with special emphasis 
being placed on understanding the mechanism involved in neuronal diseases.  
Under normal circumstances, mature retinal ganglion cells (RGCs) fail to regrow their 
axons distal to the site of optic nerve (ON) injury. Moreover, lesions often result in death 
of the severed neurons. The failure of axons to regenerate in differentiated CNS tissue has 
been attributed to several factors, such as interaction with neurite growth inhibitors [188, 
201]   or the absence of growth-promoting substrates [195, 105] . Moreover, lesions often 
result in death of the severed neurons. Recently, it has been reported that optic nerve 
transection showed typical apoptotic cell death pattern. In rats, for example, about 72% 
[191] up to 90% [14]  of the RGCs die within 2 weeks after transection of the optic nerve 
near its bulbar exit, and up to 95% of the RGCs undergo apoptosis [130] .  
However, regenerative failure is not inevitable. Adult mammalian optic nerve axons are 
able to regenerate when provided with a suitable environment. There have been numerous 
studies on the regeneration of the injured optic nerves by applying neuroprotective reagents 
or by nerve transplantation [85, 228]. Ramon y Cajal [34] described Tello’s observation 
that mature RGCs can regenerate axons through a peripheral nerve (PN) graft sutured to 
the cut end of the optic nerve and  concluded that “the regenerative failure of the central 
paths is an accidental condition, due to the neuroglial environment.” Expanding on this 
observation, Aguayo and colleagues [171, 32, 1] showed conclusively that mature RGCs 
and other CNS neurons retain an intrinsic capacity for axon growth in an altered 
environment, sparking renewed interest in the factors that support or inhibit nerve 
regeneration. All these studies constitute proof of principle  that, provided that the axonal 
environment is modified, axonal regeneration can occur in the CNS of mammals, as it does 
spontaneously in the peripheral nervous system. 
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Injury to the adult optic nerve and treatment of the corresponding retina with microglia 
inhibitors [211, 212] or with neurotrophins results in a higher incidence of survival of the 
retinal ganglion cells (RGCs). Neurotrophic effects can be mimicked by the presence of a 
peripheral nerve piece used to replace the non-permissive environment of the optic nerve 
[221, 222]. Concomitant microglia directed neuroprotection and replacement of the 
inhibitory [190, 215] distal portion of the optic nerve with a peripheral nerve graft in vivo 
[221, 211, 212], or culturing the retina in vitro [211] showed a vigorous axonal 
regeneration. 
Optic nerve transection causes irreversible degeneration of the RGC [223, 162]. The optic 
nerve provides the retina with various neurotrophic factors that are essential for the RGCs 
to survive. After axotomy, the ganglion cells ultimately die due to the deprivation of 
neurotrophins [193], altered gene expression [174, 110, 223], and various reactive oxygen 
species [99, 100]. 
The intracellular mechanisms of the nerve cell response to injury remain unknown. 
Regeneration of retinofugal axons has become one of the most prominent experimental 
models in restorative neurobiology. Understanding the mechanisms of regeneration and 
functional restoration in the central nervous system could be the first indicative steps 
towards therapeutic intervention. 
 
1.2. The Role of Astrocytes in Axonal Regeneration  
Astrocytes are the companions of neurons from the early stage of CNS formation, and are 
the most numerous cellular components of the CNS. Astrocytes have been involved in 
many functions including control of brain development and homeostasis [210], CNS 
immunity, and in regulation of development, function and efficiency of the synapse [156]. 
In the CNS of higher vertebrates, following injury, either as a result of trauma, genetic 
disorders, or chemical insult, astrocytes become reactive and respond in a typical manner, 
termed astrogliosis. Reactive astrogliosis is a prominent feature of astrocytes adjacent to 
injury.  
Moreover, astrocytes play an important role in neural plasticity. It has been reported that 
neural reorganization can take place rapidly after nervous system injury even in the adult 
brain [18], and astrocytes are thought to support synaptic sprouting, formation of new 
polysynaptic connections and the maintenance of existing neuronal circuits [63, 57]. 
Many studies have demonstrated that reactive astrocytes synthesize a variety of growth 
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factors, cytokines and components of the extracellular matrix, many of which are known to 
rescuer damage neurons in various injury models [39, 129, 141].  
 
1.2.1. Gliosis and Repair of Lesion 
Neuron-glial and glial-glial interactions are thought to play a critical role during 
development [56, 58, 65, 66, 75], in neuronal survival and death after diverse insults to 
central nervous system (CNS) [63, 76].Within the CNS, the glial cells are responsible for 
maintaining homoeostasis. When the structural integrity of the nervous system is 
compromised glial cells, it become activated to restore homeostasis [143].  
In the injured CNS, however, astrocytes appear as a key component of reactive gliosis [76, 
172], which has been considered as one of the major impediments to neurone outgrowth 
and axonal regeneration [164, 168]. It has been suggested that gliosis can induce neuron 
degeneration, either physically or through the release of inhibitory molecules [19]. As 
radial glial cells, they constitute a major substratum for the migration of neurons [163]. 
Later, they subserve major functions in neuronal homeostasis, such as ionic balance [165] 
and energy supply [38]. The reactive gliosis, which occurs after an injury to the CNS and 
leads to the glial scar, consists mainly of reactive hypertrophic astrocytes. These reactive 
cells acquire new properties, leading to a non-permissive support for neurons. The glial 
scar constitutes a physical and chemical barrier that isolates the intact tissue, but also 
contributes to the failure for recovery post-injury [22].  In addition to physical or molecular 
barriers presented by glial scarring at the lesion site, it has been suggested that the normal 
myelinated CNS environment contains potent growth inhibitors or lacks growth-promoting 
molecules. And the blockage of astrocytes reactivity yielded some axonal regeneration 
[64].  
 
1.2.2. Glial Fibrillary Acidic Protein (GFAP)  
Astrogial reactivity is mainly characterized by a high overexpression of the major 
component of the gliofilaments GFAP. This GFAP over expression is related to the 
astroglial morphological response to injury. One conspicuous phenotypic change occurring 
in astrocytes during maturation and activation is the increase in the synthesis of GFAP 
[48]. Since astrocytic hypertrophy and an attendant increase in GFAP commonly occur in 
response to all types of nervous system injury, this major alteration in activating astrocytes 
directly associated with morphological changes may be related to the functional shift from 
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neurite- promoting to neurite-inhibiting elements [143]. 
It is now well established that GFAP is the principal 8.9 nm intermediate filaments in 
mature astrocytes of the CNS [49]. As a member of the cytoskeletal protein family, GFAP 
is thought to be important in modulating astrocyte motility and shape by providing 
structural stability to astrocytic processes. Increase of GFAP mRNA has been associated 
with Scrapies, Alzheimer’s brains and Creutzfeldt-Jacob disease; was observed in a 
mechanical lesion to rat cerebral cortex, and cerebral freeze-injury [47].  
Astrogliosis is characterized by rapid synthesis of GFAP intermediate filaments. The 
involvement of GFAP in the formation of astrocytic processes was demonstrated by using 
antisense inhibition of GFAP expression [225], thus opening up the possibility of 
modulating astrogliosis induced by injury [231, 232, 61]. Since GFAP accumulation is a 
prominent feature of astrocytic gliosis, inhibit GFAP synthesis using antisense 
oligonucleotides with the intention that this might delay scar formation resulting from a 
CNS injury. The delay in the formation of a physical barrier might allow the neurons and 
oligodendrocytes to re-establish a functional environment. In vitro studies using neuron-
astrocyte co-cultures by Lefrancois et al [109] have showed that inhibition in GFAP 
synthesis leads to a reduction of astroglial hypertrophy and relieves the blockade of 
neurotic outgrowth that normally is observed after a lesion.  
  
1.3. Neuronal Growth-Associated Protein GAP-43 and Neuron Regeneration 
 
1.3.1. The Essential Role of GAP-43 during Initial Developmental Axon Growth 
It has been postulated that GAP-43 plays an essential role in axon growth. This protein is a 
phosphoprotein found in highest concentrations in axonal growth cones [199, 13] and is 
expressed in various anatomical areas of the rat brain [153]. GAP-43 is involved in 
regulation of the actin cytoskeleton, mediating a link between membrane rafts and actin 
[55, 107, 31, 90, 170] and then expression falls with maturation. 
The precise function of GAP-43 is not yet know, it has been observed to accumulate in the 
growth cone [68, 127, 198] where it is thought to play a role in signal transduction [13]. 
GAP-43 is expressed at high levels during initial developmental axon outgrowth. 
However, whether GAP-43 plays a predominant role in elongation or guidance of axons 
has been a matter of debate for many years. The overexpression of GAP-43 in PC12 cells 
[29, 91, 140, 230] or in nonneuronal cells [235] in vitro induced the formation of neurite-
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like filopodia while depletion of GAP-43 in primary sensory neurons on culture [3, 4], by 
antisense oligonucleotides resulted in the formation of thin neurites and very small growth 
cones. The overexpresssion of GAP-43 in transgenic mice also induced nerve sprouting 
[3]. On the other hand, the specific immunodetection of GAP-43 in axonal but not in 
dendritic growth cones [68, 69] supported the view that GAP-43 was mainly required for 
guidance rather than neurite elongation. 
 
1.3.2. Overexpression of GAP-43 is Associated with Neuron Regeneration 
Intrinsic factors associated with neuronal growth during embryonic development may be 
important for successful axon growth in mature neurons. Some of these factors are 
axonally transportable proteins associated with regenerative growth [196, 12]. One of the 
most abundant factors is GAP-43 which is highly expressed in developing and regenerating 
axon growth cones and in synaptic terminals of adult brain regions that exhibit plasticity 
[13, 200].  
Evidence for the involvement of GAP-43 in axonal guidance of the visual system first 
came from the observation that its expression correlated with neurite outgrowth during 
development and regeneration following nerve injury [37, 199, 196, 204]. One of the most 
prominent changes in gene expression after peripheral nervous system (PNS) axotomy is 
the increase in GAP-43 [199]. Increased expression of GAP-43 may be one component of 
a metabolic response to axotomy, which is important for regenerative growth. 
GAP-43 expression in the cell body is closely linked to both axonal growth and 
regeneration in normal animals [13, 196, 216]. In cultured neurons, it promotes neurite 
outgrowth branching and growth cone adhesion [4, 13]. An indication that the expression 
and presence of this protein in neurons may be damaging was provided by results on 
cerebella Purkinje cells of mice overexpression GAP-43 [21]. Although in the absence of 
axon injury these cells appear to survive, following axotomy, a considerable number of 
Purkinje cells died. Unlike in wild-type animals, in the transgenic animals extensive 
sprouts were seen at the site of injury [21]. GAP-43 is also playing a critical role in the 
topographic organization of the visual system [234]. However, the exact role of GAP-43 
during axon growth and synaptic function remains to be determined. 
 
1.4. Thymus-Specific Antigen (Thy-1) as RGCs marker 
Thy-1 is a cell-surface signalling molecule of the immunoglobulin (Ig) superfamily 
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implicated in the regulation of neurite outgrowth, synaptic function and plasticity [132]. 
Although Thy-1 is a surface component of most neurons in the adult nervous system, it is 
present only on certain neurons during early development. Moreover, detectable antigen 
can be lost from cells which at earlier development were Thy-1 positive, whereas formerly 
Thy-1 negative cells can acquire high levels of the antigen during later stages of 
development. Thy-1 appears to be critically involved in neuron development [185]. 
In the eye, Thy-1 is found predominantly in the ganglion cell layer (GCL), with some 
staining also seen in the nerve fibre and inner plexiform layers (IPLs) [9]. Thy-1 can be 
detected in the inner retina of rats from the date of birth. However, levels were very low 
for the first few days of postnatal development. There was a sharp increase in Thy-1 levels 
at postnatal day 5, which reached a maximum towards the end of the second postnatal 
week. Thy-1 declined minimally from this point on, and remained at relatively constant 
level in adulthood [115]. 
The Thy1 gene codes for a 25 kDa cell surface glycoprotein [226] of unknown function. It 
is predominantly expressed by ganglion cells in the retina [9, 154], making it a useful 
marker for evaluating gene expression in these cells. Previous studies have shown that 
Thy1 message and/or protein were depleted after damage to the optic nerve and retina 
[154, 147, 106, 136], an observation that has been attributed to the loss of ganglion cells in 
affected retinas. In other experiments, however, the loss of Thy1 expression appeared to 
precede cell death [111]. Compared to the number of cells expressing Thy1 and the rate of 
cell loss in retinas exposed to two acute damaging stimuli in mice and chronic elevated 
IOP in a rat model of experimental glaucoma, Thy1 mRNA levels decreased prior to 
significant cell loss [184]. In addition, Thy1 expression also decreased in ganglion cells 
resistant to cell death, suggesting that this downregulation precedes a committed step in the 
apoptotic program of these cells. 
 
1.5. ET-1 and ETB 
Endothelin (ET) has been implicated in such a role as it can induce significant changes in 
the physiology of cultured astrocytes. ET promotes mitogenesis and increases intracellular 
Ca2+ levels [207, 117], increases nerve growth factor expression [103]. This peptide, first 
isolated from vascular endothelial cells [229], is localized in the CNS, and of its known 
isoforms (ET-1, ET-2, and ET-3) only ET-1 and ET-3 are found in neurons [62] and 
astrocytes [117]. ET agonists can stimulate astrocyte ET-1 production in vitro [40, 41]. The 
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biological actions of ET-1 are primarily mediated by two receptor subtypes, termed 
endothelin A receptor (ETA) and endothelin B receptor (ETB), cloned and sequenced in 
mammals [5, 178]. The ETA receptors have selective affinity for ET-1 whereas the ETB 
receptors have equal affinity for all isoforms.  
 
1.5.1. Modulation Astrocyte Function in CNS 
ET-1 is known to induce vasoconstriction of cerebral vessels resulting in decreased 
cerebral blood flow and neuronal damage [119]. The increased risk of late vasospasm of 
the basilar artery after head injury may be related to the loss of ETB -receptor expression 
and ETB -mediated vasodilation after neurotrauma [67]. Apart from a direct effect on the 
cerebral vasculature, lack of ETB receptors may also result in an impairment of other 
cellular functions. ETA and ETB receptors are responsible for transducing the peptide's 
effects in the CNS; however, the ETB receptor has been shown to be the primary receptor 
expressed on astrocytes in vitro [42]. Astrocytic endothelin receptors have autoregulatory 
[43] and eliminatory [74] tasks and also modulate astroglial activation [101], proliferation 
[207] as well as the permeability of astrocytic gap-junctions [17].Functional ETB receptors 
have been found to protect this vulnerable cell population from apoptosis [44]. ETB 
receptor which expressed by the majority of astrocytes were immunoreactive for GFAP in 
both the normal and crushed rabbit optic nerve. Optic nerve crush induced a marked 
increase in ETB receptors and GFAP immunoreactivity without inducing a significant 
increase in the number of GFAP immunoreactivity astrocytes, suggesting that the crush-
induced astrogliosis is due primarily to astrocyte hypertrophy. Pharmacological blockade 
of astrocyte ETB receptors following CNS injury modulates glial scar formation and may 
provide a more permissive substrate for neuronal survival and regeneration [175]. 
Astrocytic endothelin receptors, e.g., mediate a reduction of gap-junctional permeability 
[17], thereby profoundly influencing astrocytic communication and also the propagation of 
apoptotic signals [114]. Autoregulatory and eliminatory functions of astrocytes rely on 
functional ETB receptors [43, 74]. Interestingly, the expression of ETB -receptor 
immunoreactivity was increased in the reactive astrocytes of lesioned brain indicating 
perhaps an attempt of the injured neural tissue to restrict the propagation of damage. 
Finally, microglial ETB signaling might also be involved in the modulation of brain 
damage [227]. 
 
  
-8- 
1.5.2. The Actions of ET-1 in Retina Neurons and Glia 
The presence of the ET system in the eye is well established. ET-1 mRNA expression has 
been detected in the whole rat retina [24]. ETA and ETB are present in neural retinal rat 
membranes [33]. Autoradiographic studies have shown that ETB receptors are present in 
neurones and glial cells of the neural retina [118]. The existence of both ET-1 and GFAP 
immunoreactivities within astrocytes in human and porcine retinas indicate that ET-1 may 
also be formed and stored within retinal glial cells thus playing a role in glial function 
[173]. The physiological significance of ET-1 expression in retinal glial elements is for the 
moment unknown. Astrocytic proliferation together with an excessive secretion of ET-1 
have been reported in vivo, such as in cerebral focal ischemia, and subarachnoid 
haemorrhage [139, 227] Moreover, Sasaki et al. [180] demonstrated that ET-1 specifically 
stimulated the efflux of glutamate via ETB receptors from cultured of rat astrocytes 
suggesting that ET-1 may exacerbate neuron degeneration. On the other hand, ET-1 acts as 
a growth factor for astrocytes, inducing DNA synthesis and proliferation [117]. 
The expression of ET-1 in neural, glial as well as vascular elements of the normal adult 
retina suggest that ET-1 may have a role in the maintenance of both neural and vascular 
integrity in the mature retina. 
 
1.6. Nuclear Factor kappa B (NF-κB) 
Nuclear factor kappa B (NF-κB), as a transcription factor, is one of the molecules involved 
in cell death. NF-κB exists in the cytoplasm as heterodimers or homodimers of Rel related 
proteins. The amino terminal region of the Rel homology domain contains DNA binding, 
dimerization, and nuclear localization domains. The predominant form of NF-κB is 
composed of NF-κB1 (p50) and RelA (p65), and is associated with inhibitor-κB (IκB) as 
an inactive form. Upon stimulation, I-κB is phosphorylated by IκB kinases, ubiquitinated, 
and subsequently processed to proteolytic degradation. The freed NF-κB translocates from 
the cytoplasm to the nucleus by exposing the nuclear localization signal and then binds to 
the target genes to activate transcription [128, 146]. NF-κB is activated by various stimuli, 
including stress or injury. So far, the known inducers for NF-κB activation are interlukin 
(IL)-1, tumor necrosis factor alpha (TNF-α), bacterial lipopolysaccharides, 
sphingomyelinase, oxygen free radicals, ultraviolet light and γ-irradiation [84, 155, 203]. 
The mechanism for anti-apoptotic role of NF-κB is suggested as the elevation of Bcl-2 
expression by NF-κB. Furthermore, p50 knockout mice showed increased apoptosis and 
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the survival pathway by growth factors or cytokines also activate NF-κB through PI-3 
kinase pathway [108, 131, 176, 208, 224, 233]. 
 
1.6.1. NF-κB in the Nervous Cells  
NF-κB is widely known for its ubiquitous roles in inflammation and immune responses, as 
well as in control of cell division and apoptosis. These roles are apparent in the nervous 
system, but neurons and their neighbouring cells employ the NF-κB pathway for 
distinctive functions as well, ranging from development to the coordination of cellular 
responses to injury of the nervous system and to brain-specific processes such as the 
synaptic signalling that underlies learning and memory [124]. 
In the nervous system, NF-κB is modulated under physiological and pathological 
conditions, including developmental cell death and acute or chronic neurodegenerative 
disorders [8, 123]. The activation of NF-κB as a pro-apoptotic factor has been shown in 
neuronal cell death induced by TNF-α, glutamate, and reactive oxygen species in vitro [71, 
70, 122, 159], while the anti-degenerative function also has been suggested. The activated 
NF-κB plays a protective role from the cell death in the injured ganglion cells [27]. NF-κB 
was observed in the ganglion cell layer after axotomy with immunohistochemistry [26]. It 
has been associated with synaptic plasticity since NF-κB is present in synaptic terminals 
and can be activated locally in such synapses [93, 126]. Moreover, physiological signals 
such as glutamate receptor binding and membrane depolarization induce NF-κB activation 
in hippocampal pyramidal neurons and cerebellar granule neurons in cell culture [70, 72, 
94]. NF-κB activity is also greatly increased in brain cells following excitotoxic and 
apoptotic insults. In addition, activation of NF- κB before experimental insults such as 
exposure to glutamate, glucose deprivation, β-amyloid peptide, or oxidative molecules has 
been shown to protect neurons against apoptosis [6, 25, 92]. In contrast, treatment of 
neurons with κB decoy DNA that selectively blocks NF-κB activity abolished the 
protective effect of small doses of TNF-α [122]. In vivo, administration of κB decoy DNA 
to mice via intraventricular infusion before administration of the glutamate agonist kainite 
resulted in a significant increase of neuronal death in the CA1 and CA3 regions of the 
hippocampus, and mice lacking p50 exhibited increased damage to hippocampal pyramidal 
neurons [233]. Finally, studies of postmortem brain tissues from patients with 
neurodegenerative diseases such as Alzheimer's or Parkinson's diseases revealed increased 
NF-κB activity closely associated with the neurodegenerative process [86, 92].  These 
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results strongly suggest that NF-κB regulates apoptosis in response to stress in the nervous 
system, in addition to regulating apoptosis in a large variety of cells and tissues.  
 
1.7. Heat Shock Proteins  
Heat shock proteins (HSPs) represent a family of stress –activated proteins that participate 
in protein folding, repair, and degeneration [202]. HSPs range in molecular weight from 10 
to 170 kDa. Although these proteins were initially identified in Drosophila in response to 
heat stress, they are found in all cells, and their expression is upregulated in response to 
different forms of cellular stress. The primary physiological function of HSPs is to act as 
molecular chaperones that assist in protein folding. Other functions include participation in 
activation of glucocorticoid receptors, polymerisation of actin, and transfer of proteins to 
lysosomes [202]. In addition, overexpression of specific HSPs has been shown to prevent 
apoptotic cell death [95, 11, 59]. The induction of HSPs involves both transcriptional 
activation and translational changes. Studies have provided evidence that depletion of 
adenosine triphosphate (ATP) and the induction of the mitogen-activated protein (MAP) 
kinase pathway play significant roles in the activation of specific HSPs [160].  
HSPs are induced in the cells of many types of tissues by stressful stimuli and play 
important roles in cellular repair and protective mechanisms. Increasing attention is being 
focused on the neuroprotective effects of relatively low-molecular-weight HSPs, including 
HSP27 and HSP32, in the event of heat shock or other injuries [10, 23]. HSP27 has been 
shown to interact with the actin cytoskeleton, to modulate intracellular reactive oxygen 
species content, and to prevent apoptotic cell death triggered by a variety of stimuli, 
including TNF-α [60, 83]. Several mechanisms have been proposed to account for the 
HSP27-mediated negative regulation of programmed cell death. This small HSP 
specifically interacts with cytochrome c when released from the mitochondria to the 
cytosol, thus preventing the formation of the apoptosome. A premitochondrial effect at a 
higher HSP27 expression level has also been described [149, 179]. In vitro, this protein 
behaves as an ATP-independent chaperone that helps in the refolding of denatured proteins 
[138], a property that could be of key importance for understanding its in vivo functions. 
In vivo studies demonstrated that transection of the optic nerve results in the expression of 
HSP27 in the visual system. HSP27 may be associated with enhanced survival of a subset 
of retinal ganglion cells, providing evidence of a protective role for HSP27 in CNS after 
neuronal injury [102]. And an increase in expression of HSP27 appears to be one 
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component of the neuroprotective events induced by ischemic preconditioning in the retina 
[112]. 
When overexpressed in response to various stimuli, HSP27 facilitates phosphorylated I- 
κBα proteasome-mediated proteolysis, which could account for the protective effect of this 
small stress protein [148].  
 
1.8. The Aim of this Project 
The ability of the adult mammalian central nervous system (CNS) to regenerate following 
injury is influenced by a balance between factors that promote and those that inhibit 
neuronal survival, regeneration, and sprouting. While the properties of the injured neurons 
affect the extent of neuronal survival and regeneration, glial cells at the site of injury are 
also critically involved in determining the regenerative outcome [53, 161]. The molecular 
mechanisms underlying neuronal degeneration, repair and regeneration after axon injury 
have yet to be identified.  
It is therefore of crucial importance to characterize the different populations of cells, which 
may codetermine whether regeneration will take place or not. In this study the optic nerve 
of adult rats was transect (axotomy-group) or the optic nerve was transect and replaced 
with an autologous graft (grafting-group) to facilitate axonal regeneration.  
To gain further insights into the molecular mechanisms responsible for regeneration of 
retina, the semi-quantitative RT-PCR, real time PCR and immunohistochemistry method 
were performed for differentials genes and protein expression in the retina. The purpose of 
the present study was to search for changes in gene expression in the regenerating retina 
following optic nerve grafting. We conducted a comparison of mRNAs in those retinas 
receiving PN grafted with those axotomized and used untreated retinas as controls. At 
various times elapsed after injury, those glial cell markers, neuronal markers and capillary 
endothelin were analysed. 
 
1.9. Injury Model and Methods Used 
 
1.9.1. Animal Model of Optic Nerve Axotomy and PN Grafting 
The optic nerve has served as an important model for the study of the neuro/nonneuronal 
response to injury and to study axon regeneration in the CNS [54, 221, 222, 15]. Retinal 
ganglion cells and their associated projections to the brain have recently become an 
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attractive experimental model to study the issue of axonal regeneration in the CNS [35, 80, 
88]. A number of experimental manipulations have been found to enhance the axonal 
regeneration of rodent RGCs after injury of the ON apposition of a peripheral nerve 
segment to the cut ON. Analysis of axon sprouting and regeneration after injury by 
anatomical tracing are aided by lesion models that produce a well-defined injury site. 
Retinal ganglion cells have historically been a model cell-type for study both in vitro and 
in vivo, since they represent an accessible population of neurons of the central nervous 
system and have been examined in numerous experimental paradigms. Ganglion cells are 
also the primary retinal cell-type affected by several blinding diseases including glaucoma, 
tumor-associated optic nerve compression, and ischemic optic neuropathy. 
 
1.9.2. Real Time Quantitative PCR 
Real-time quantitative RT-PCR is the method of choice used to quantify mRNA expression 
of cytokines, which are often expressed at very low levels. It quantitates the initial amount 
of the template most specifically, sensitively and reproducibly, and is a preferable 
alternative to other forms of quantitative RT-PCR, which detects the amount of final 
amplified product. Real-time PCR monitors the fluorescence emitted during the reaction as 
an indicator of amplicon production during each PCR cycle (i.e., in real time) as opposed 
to the endpoint detection by conventional quantitative PCR methods. Real-time PCR 
quantitation eliminates post-PCR processing of PCR products (which is necessary in 
competitive RT-PCR). This helps to increase throughput, reduce the chances of carryover 
contamination and remove post-PCR processing as a potential source of error. In 
comparison to conventional RT-PCR, real-time PCR also offers a much wider dynamic 
range of up to 107-fold (compared to 1000-fold in conventional RT-PCR). This means that 
a wide range of ratios of target and normalizer can be assayed with equal sensitivity and 
specificity. It follows that the broader the dynamic range, the more accurate the 
quantitation. 
The real-time PCR system is based on the detection and quantitation of a fluorescent 
reporter. This signal increases in direct proportion to the amount of PCR product in a 
reaction. By recording the amount of fluorescence emission at each cycle, it is possible to 
monitor the PCR reaction during exponential phase where the first significant increase in 
the amount of PCR product correlates to the initial amount of target template. The TaqMan 
probes [79] use the fluorogenic 5' exonuclease activity of Taq polymerase to measure the  
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amount of target sequences in cDNA samples. TaqMan probes are oligonucleotides longer 
than the primers (20-30 bases long with a Tm value of 10 oC higher) that contain a 
fluorescent dye usually on the 5' base, and a quenching dye (usually TAMRA) typically on 
the 3' base. When irradiated, the excited fluorescent dye transfers energy to the nearby 
quenching dye molecule rather than fluorescing (this is called FRET = Förster or 
fluorescence resonance energy transfer). Thus, the close proximity of the reporter and 
quencher prevents emission of any fluorescence while the probe is intact. TaqMan probes 
are designed to anneal to an internal region of a PCR product. When the polymerase 
replicates a template on which a TaqMan probe is bound, its 5' exonuclease activity 
cleaves the probe. This ends the activity of quencher (no FRET) and the reporter dye starts 
to emit fluorescence which increases in each cycle proportional to the rate of probe 
cleavage. Accumulation of PCR products is detected by monitoring the increase in 
fluorescence of the reporter dye.  
TaqMan assay uses universal thermal cycling parameters and PCR reaction conditions. 
Because the cleavage occurs only if the probe hybridizes to the target, the fluorescence 
detected originates from specific amplification. The process of hybridization and cleavage 
does not interfere with the exponential accumulation of the product. One specific 
requirement for fluorogenic probes is that there is no G at the 5' end. A 'G' adjacent to the 
reporter dye quenches reporter fluorescence even after cleavage. 
The threshold cycle (Cт) value is the cycle at which a significant increase in ∆Rn is first 
detected. The threshold cycle is when the system begins to detect the increase in the signal 
associated with an exponential growth of PCR product during the log-linear phase. This 
phase provides the most useful information about the reaction (certainly more important 
than the end point). The important parameter for quantitation is the Cт. The higher the 
initial amount of cDNA, the sooner accumulated product is detected in the PCR process, 
and the lower the Cт value.  
Relative gene expression comparisons work best when the gene expression of the chosen 
endogenous control is more abundant and remains constant, in proportion to total RNA, 
among the samples. By using an endogenous control as an active reference, quantitation of 
an mRNA target can be normalized for differences in the amount of total RNA added to 
each reaction. The use of this endogenous reference also normalizes for variation in reverse 
transcriptase efficiency among the different cDNA reactions. For this purpose, the most 
common choices are 18S RNA, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and 
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β-actin.  
The real-time quantitative PCR method measures PCR product accumulation through a 
dual-labeled fluorogenic probe. This method provides very accurate and reproducible 
quantitation of gene copies. Unlike other quantitative PCR methods, real-time PCR does 
not require post-PCR sample handling, preventing potential PCR product carry-over 
contamination and resulting in much faster and higher throughput assays. The real-time 
PCR method has a very large dynamic range of starting target molecule determination. 
Real-time quantitative PCR is extremely accurate and less labour-intensive than current 
quantitative PCR methods. 
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2. Materials and Methods 
 
2.1. Surgical Techniques 
 
2.1.1. Material 
CO2 Gas     Autolab PGStat 12, Nederland 
10/0 suture (10-0 silk)    Ethicon, Hamburg, Germany 
Operating microscope    OPMI 19, Zeiss, Jena, Germany) 
 
2.1.2. Animals and Anaesthesia 
Lister-Hooded rats, female    
10% ketamine    Sanofi-Synthelabo, Paris, France 
2% Xylazine    Sanofi-Synthelabo, Paris, France 
The studies were performed at University of Münster. Totally 40 Adult female Lister 
hooded rats (Charles River Laboratories, Germany), weighting 200-230g and aged between 
8 to 10 weeks were used for the experiments. 
 
2.1.3. Surgical Procedures  
Animals were handled in accordance with the ARVO Statement for the Use of Animals in 
Ophthalmic and Vision Research, and were approved by the authorities Institutional 
Animal Care and Use Committee (University of Münster). Lister-Hooded rats were given 
free access to food and water under a normal 12 hour light-dark cycle. The rats were 
anesthetized by intraperitoneal injection of 10% ketamine (60–80 mg/kg) and 2%xylazine 
(10–15 mg/kg). Surgery was performed under visual control using an operating 
microscope. The rats were killed by CO2 inhalation at various points, and the eyes were 
enucleated.  
 
2.1.3.1. Optic Nerve Transection 
Degeneration of RGCs was achieved by complete transection of the ON. The head of the 
anesthetized animal was positioned and fixed in a head-holder. A 1.5-2 cm incision was 
made in the skin above the left orbit. The ON was surgically exposed in its intraorbital 
segment under a surgical microscope. After partial resection of the lachrymal glands and 
extraocular muscles, the meninge of the optic nerve was opened longitudinally. Avoiding 
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injury to the ophthalmic artery, the ON was transected with microscissors at a distance of 
0.5 mm behind the eye. The blood flow of retina was monitored by using a direct 
ophthalmoscope during the surgery.  
 
2.1.3.2. Grafting of Peripheral Nerve Segments 
The meninge of the left ON was opened and the nerve was completely transected 
intraorbitally 0.5 mm behind the optic nerve head. A 1.5 cm segment of autologous 
peripheral nerve (PN) was obtained from the peroneal branch of the right sciatic nerve 
(SN) and transplanted onto the ON stump using 10/0 suture (10-0 silk), as previously 
described in detail [221]. 
 
2.1.4. Animal Experimental Design 
The RGCs regeneration mediated characterization study comprised three groups of 
animals: one control group were normal animals without any surgical treatment (N=6); 
another group of animals served with ON axotomy (n=15); the third group of animals were 
those with transected ON and grafting of a segment of PN to the cut end of the optic nerve 
(n=18). Axotomized rats were divided into two groups (n=3 per group) surviving for either 
5 or14 days after optic nerve cut for immunostaining; and three groups (n=3 per group) for 
5, 14 and 21 days for RNA isolation. The grafted rats were divided into three groups (n=6 
per group), surviving for 5, 14, and 21 days after optic nerve cut and simultaneous PN 
grafting. All animals were sacrificed on each time schedule; left eyes were enucleated for 
immunohistochemistry and molecular analysis.  
 
2.2. Immunohistochemistry 
 
2.2.1. Preparation of Tissue Sections  
Tissue-Tek O.C.T. compound    Sakura Company, 
    Torrance, CA, USA 
Gelatin-coated glass slides   Superfrost Plus;  
    Fisher Scientific 
Immediately following surgical eye removal, the whole eye was embedded in Tissue-Tek 
O.C.T. compound and then snap-frozen in liquid nitrogen. Frozen sections (10-12 µm) 
were cut longitudinally on a cryostat, and were thaw-mounted on gelatin-coated glass, 
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maintained at -20 °C until use.  
2.2.2. Immunohistochemistry  
The sections were incubated with antibodies to visualize the microenvironment within the 
retina. 
2.2.2.1. Material 
DAPI    Hoechst 
10% fetal calf serum (FCS)    Carlsbad, CA, USA 
Mowiol    Hoechst, Germany) 
Microscope    Axiophot, Zeiss; Germany 
 
2.2.2.2. Antibodies 
 
2.2.2.2.1. First Antibody 
Rabbit Anti-Hsp25 polyclonal 
Antibody (SPA-801)    Stressgene 
Rabbit Anti-NF-κB p65 poly- 
clonal Antibody (sc-109)    Santa Cruz 
Rabbit Anti-I-κB-α polyclonal  
Antibody (sc-371)    Santa Cruz 
Rabbit Anti-Endothelin poly- 
clonal Antibody (E-1645)    Sigma 
Mouse Anti-Rhodopsin mono- 
clonal antibody (MAB5316)    Chemicon International 
Mouse Anti-GAP-43 mono- 
clonal antibody (G9264)     Sigma 
Mouse Anti-GFAP mono- 
clonal antibody (G3893)     Sigma 
 
2.2.2.2.2. Second Antibody 
CyTM2-conjugated*AffiniPure  
F (ab´) 2 Fragment Goat  
Anti-Mouse IgG (H+L)    Jackson ImmunoResearch,  
    Westgrove, PA, USA 
  
-18- 
CyTM2-conjugated*AffiniPure  
Goat Anti-Rabbit IgG (H+L)   Jackson ImmunoResearch,  
    Westgrove, PA, USA  
 
2.2.2.3. Immunohistochemistry Procedure 
1) Frozen sections were fixed in cold methanol (store at -20oC) for 10 mins. 
2) Washed 3 x 5 mins in phosphate buffer saline (PBS). 
3) Blocked with 10% fetal calf serum (FCS) in a humid chamber for 30 mins at room 
temperature. 
4) The first antibody was diluted in FCS with different dilution (GAP-43 1:100; 
GFAP 1:400; the others 1:200), and the sections were incubated overnight at 4 oC. 
5) After rinsing the slides for 3 x 5 mins in PBS. 
6) The sections were incubated with an appropriate fluorescein-conjugated second 
antibody (1:200) for 30 mins at room temperature. 
7) Wash 3 x 5 mins in PBS. 
8) Finally the slides were cover-slipped using Mowiol with DAPI to stain nuclear, and 
viewed with the appropriate filter under a fluorescence microscope at a final 
magnification of x 200 or x 400.  
9) Control samples were treated without the primary antibodies. 
2.3. Molecular Biology Work 
 
2.3.1. Handling RNA 
Ribonucleases (RNases) are very stable and active enzymes that generally do not require 
cofactors to function. RNases are difficult to inactivate and even minute amounts are 
sufficient to degrade RNA. When handling RNA, proper microbiological, aseptic 
techniques should always be used to avoid RNase contamination. Creating and maintaining 
an RNase-free environment, always wear gloves while handling regents and RNA samples. 
Use sterile, disposable plastic ware and filtered pipette tips. All solutions should be made 
with DEPC treated water. Glassware should be baked at 180 oC for 5 hours. To minimize 
degradation of RNA by limiting the activity of endogenous RNases, store RNA at -80 oC. 
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2.3.2. DEPC H2O 
0.1% DEPC H2O 1000ml 
 1000 ml bidistilled H2O 
 1 ml  DEPC (Diethylpyrocarbonate) 
Stirred for 6-8 hours at room temperature; then let incubate overnight in a fume hood. The 
next day residual DEPC is removed by autoclaving. Solution was stored at room 
temperature. 
 
2.3.3.  RNA Extraction 
 
2.3.3.1. Buffer, Enzyme and Chemicals     
RNeasy Mini Kit (74104):   QIAGEN GmbH, Germany 
Buffer RLT          
Buffer RW1       
Buffer RPE       
RNase-free water       
RNase-Free DNase Set (79254):   QIAGEN GmbH, Germany 
DNase I (1500 Kunitz units)    
Buffer RDD      
RNase-free water       
100% Ethanol    Merck 
70% Ethanol    Merck 
β-Mercaptoethanol (β -ME)   Merck 
 
2.3.3.2. Expendable Material and Devices  
RNeasy mini spin columns   QIAGEN 
Collection tubes (1.5, 2 ml)   QIAGEN 
20-gauge needle RNase- free syringe   
Microcentrifuge    Heraeus 
Spectrophotometer    Eppendorf 
Vortex-Genie 2    Scientific Industries  
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2.3.3.3. RNA Isolation Procedure 
Total RNA from retina was extracted using the RNeasy Mini Kit according the protocol of 
the manufacture. Contaminating DNA was removed with RNase-free DNase. 
1) Pooled the retina (not more than 30mg) in 350µl buffer RLT with fresh added β –ME 
(1:100). 
2) Homogenized retina tissue by passing legate at least 5 times through a 20-gauge 
needle fitted to an RNase- free syringe.  
3) Centrifuge the tissue lysate for 3 min at 13,000rpm speed in a microcentrifuge. 
Carefully transferred the supernatant to a new microcentrifuge tube by pipetting. 
4)  Added 1 volume (350µl) of 70%ethanol to the cleared lysate, and mixed immediately 
by pipetting. 
5) Transferred all solution including any precipitate to an RNeasy mini column placed in 
a 2 ml collection tube, centrifuge for 1 min at >10,000 rpm. Discarded the 
flowthrough. 
6) Pipetted 350µl Buffer RW1 into the spin column, and centrifuge 15 sec at >10,000 
rpm. Discarded the flowthrough. 
7) Added 10µl DNase stock solution to 70µl Buffer RDD, mixed gently. Pipetted whole 
80µl incubation mix onto the spin column membrane, and placed on the bench top for 
15 min in room temperature. 
8) Pipetted 350µl Buffer RW1 into the spin column, and centrifuge 15 sec at >10,000 
rpm. Discarded the flowthrough. 
9) Transferred the RNase column into a new collection tube. Pipetted 500µl Buffer RPE 
onto the column, and centrifuge 15 sec at >10,000 rpm. Discarded the flowthrough. 
10)  Added 500µl Buffer RPE onto the column, and centrifuge 2 min at >10,000 rpm. 
11)  To elute, transferred the RNase column into a new collection tube, add 30µl RNase-
free water onto the membrane, centrifuge 1 min at >10,000 rpm. Added 30µl RNase-
free water; centrifuge 1 min to get a total volume of 60µl RNA. 
The concentrations of RNA were determined by measuring absorbance at 260 nm (A260) in 
a spectrophotometer. The ratios (A260/A280) of all samples were between 1.75 and 2.00. 
 
2.3.4. Reverse Transcription (RT) 
 
2.3.4.1. Material 
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M-MLV Reverse Transcriptase   Promega 
5X Reaction Buffer    Promega 
DTT (100mM)    Promega 
dNTP’s    Amersham 
oligo-d(T)-Primer (5´-pd(T)12-18-3´) Promega 
Different size of filter tips    Greiner 
Eppendorp (0.5, 0.2 ml), RNase- free Biozym 
Filter tips, RNase- free    Greiner 
 
2.3.4.2. Devices 
Blockthermostat BT 200    Kleinfeld Labortechnic 
Trio-Thermoblock    Biometra 
-20oC Freezer    AEG 
 
2.3.4.3. Procedure 
The RNA-dependent DNA-polymerase activity (reverse transcription, RT) transcribes 
complementary DNA (cDNA) from an RNA template. This activity allows synthesis of 
cDNA for cloning, PCR, RNA sequencing, and primer extension. Total RNA (1ng) was 
used to generate first strand cDNA by random priming with reagents and protocols used as 
recommended by manufacturers. RNA was reverse-transcribed using M-MLV reverse 
Transcriptase.  
Component   Volume/reaction  Final concentration  
Master Mix 
5x Buffer RT    5.0µl    1x 
DTT (100mM)    2.0µl    10nM 
dNTP’s (10mM)    1.0µl    5mM 
Oligo-d(T) primer (10µM)   1.0µl    1µM 
RNase inhibitor    1.0µl    20µ 
M-MLV    1.0µl    200µ 
RNase- free water    Variable 
Template RNA    Variable   1ng         
Total volume    20.0µl    -  
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1) Thawed template RNA solution on ice. 
2) For each template RNA sample, pipeted variable volume with containing 1ng 
RNA, add RNase-free water to bring a total volume of 9.0µl. 
3) For denaturation, incubated for 10 min at 70 oC. 
4) Immediately put on ice for 10 min. 
5) Prepared a fresh Master Mix on ice according to the table above. 
6) Added 11µl Master mix to the individual tubes containing the denatured of 
template RNA, mix by pipeting. 
7) Incubated for 60 min at 37 oC. 
8) To inactivate M-MLV Reverse Transcriptase by heat the reaction mixture to 93 for 
5 min followed by rapid cooling on ice. 
9) cDNA were keeping in -20 oC for further use. 
 
2.3.5. Polymerese Chain Reaction (PCR) 
 
2.3.5.1. Devices 
GeneAmp PCR-System 9700     Perkin Elmer 
 
2.3.5.2. Material 
TITANIUMTM Taq DNA Polymerase Kit (8434-1) Clontech 
 Taq DNA Polymerase 
 10X Taq PCR Buffer 
 
2.3.5.3. Primers 
Primer pairs were carefully chosen to avoid amplification of genomic DNA. Primers were 
picked up from the sequence by using program “Primer3”. As the stably expressed 
reference gene (housekeeping gene) β-actin was used. 
β-actin primers 
 forward, 5’-CGCAGTTGGTTGGAGCAAAC-3’ 
 reverse, 5’-AAGCAATGCTGTCACCTTCCC-3’ 
 products 225 bp 
GFAP primers 
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 forward, 5’-GCTTACTACCAACAGTGCC-3’ 
 reverse, 5’-CCACCGTCTTTACCACGAT-3’ 
 products 853 bp 
Hsp27 primers 
 forward, 5’-CCTCTTCGATCAAGCTTTCG-3’ 
 reverse, 5’-CTTTCTTCGTGCTTGCCAGT-3’ 
 products 318 bp 
Endothelin-1 primers 
 forward, 5’-ACTTCTGCCACCTGGACATC-3’ 
 reverse, 5’-GGCTCGGAGTTCTTTGTCTG-3’ 
 products 200 bp 
EAAC-1 primers 
 forward, 5’-AGAAATTCTGATGCGGATGC-3’ 
 reverse, 5’-GGCAGGCTTCACTTCTTCAC-3’ 
 products 349 bp 
Stat 6 primers 
 forward, 5’-GGGGACTGCTACCAGAACACT-3’ 
 reverse, 5’-ATCTGTGAGGAGCCATCCTG-3’ 
 products 358 bp 
Stat 3 primers 
 forward, 5’-GACCCGCCAACAAATTAAGA -3’ 
 reverse, 5’-CGACATCCCCAGAGTCCTTA -3’ 
 products 299 bp 
Rhodopsin primers 
 forward, 5’-GGATTCACCACCACCCTCTA -3’ 
 reverse, 5’-CAATCCCACATGAACACTGC -3’ 
 products 301 bp 
Calmodulin primers 
 forward, 5’-ACTGGGTCAGAACCCAACAG -3’ 
 reverse, 5’-TTAGCTTTTCCCCGAGGTTT -3’ 
 products 236 bp 
GM-CSF primers 
 forward, 5’-GATGCCATCAAAGAAGCTCTG -3’ 
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 reverse, 5’-AGTGGCTGGCTATCATGGTC -3’ 
 products 202 bp 
Thy-1 primers 
 forward, 5’-GGTGAACCAGAACCTTCGAC -3’ 
 reverse, 5’-CAGCAGCCAGGAAGTGTTTT -3’ 
 products 346 bp 
Parvalbumin primers 
 forward, 5’-GGCCTGAAGAAAAAGAGTGC -3’ 
 reverse, 5’-TTCTTCAACCCCAATCTTGC -3’ 
 products 204 bp 
GAP-43 primers 
 forward, 5’-GGCTCTGCTACTACCGATGC -3’ 
 reverse, 5’-GGCTTGTTTAGGCTCCTCCT -3’ 
 products 225 bp 
HO-1 (Hsp32) primers 
 forward, 5’-AAGGCTTTAAGCTGGTGATGG -3’ 
 reverse, 5’-AGCGGTGTCTGGGATGAACTA -3’ 
 products 669 bp 
 
Component   Volume/reaction Final concentration  
Master mix 
10x Buffer    2.5µl   1x 
dNTP’s (25mM)    1.0µl   0.2mM 
forward primer (100pmol/µl)   0.125µl  0.5pmol/µl 
reverse primer (100pmol/µl)   0.125µl  0.5pmol/µl 
A-Taq DNA Polymerase (20 µ/µl)  0.125µl  0.05µ/µl 
RNase- free water    19.48µl 
Template RNA    2.5µl        
Total volume    25.0µl     
 
2.5 µl of RT reaction, representing 1ng input RNA was used as template for PCR 
amplification in a 25µl reaction volume. cDNA was amplified by PCR using Taq 
polymerase. Specific 20 base oligonucleotide primer pairs were added to the PCR reaction 
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vials and 35 cycles were performed at 30 sec 94 oC, 30 sec 60 oC, and 30 sec 72 oC. PCR 
were carried out in a Perkin-Elmer 9700 thermocycler. Each primer pair amplified a single 
band of the expected sized. No template control served without cDNA, instead of RNase-
free water.  
 
2.3.6. Gel Electrophoresis PCR Products 
Buffers and Chemicals: 
Phosphate buffer saline (PBS), pH 7.4 
NaCl   9g/l   Sigma 
KH2PO4   0.27g/l   Sigma 
Na2HPO4 x 2 H2O   1.42g/l   Sigma  
 ad H2O to total volume 1,000 ml  
5X TBE running buffer (Tris-Borat-EDTA-Buffer), pH 8.0 
Tris (Tris-(Hydroxymethyl 
-aminomethan))   54.0g/l   Merck 
Boric acid   27.5g/l   Sigma 
Na2EDTA x 2 H2O   3.72g/l   Merck 
 ad H2O to total volume 1,000 ml 
5X TE buffer (Tris-EDTA), pH 8.0 
10mM Tris/HCl   Merck 
1mM EDTA   Merck 
 ad DEPC-water to total volume 1,000ml 
6X Ficoll-buffer, 0.4 ml 
60% (w/v) Ficoll  100µl   Sigma 
1% Bromophenol blue  100µl   Sigma 
RNase-free water  200µl   Sigma 
Seakem-LE-Agarose      FMC Bioproducts 
Ethidium Bromide      Sigma  
Digital gel Camera      Zeiss  
5.0µl PCR-amplified DNA fragments were resolved on 1.5% agarose gel containing 0.4 
µg/ml ethidium bromide, running with 1X TBE buffer at 120 V, 40 mins. Bands were 
visualized with 302 nm UV light and photographed using a digital gel camera.  
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2.3.7. Quantitative Real-Time PCR 
 
2.3.7.1. Material 
2x TaqMan Universal PCR  
Master Mix (P/N 4324018)     Applied Biosystems 
96-well optical reaction plates    Applied Biosystems     
TaqMan probes     MWG, The genomic 
     Company, Germany 
Primers     MWG, The genomic 
    Company, Germany 
 
2.3.7.2. Device 
ABI 5700 Sequence Detector     Perkin Elmer,     
     Foster City, CA, USA 
Primer Express version 1.0 software   Perkin Elmer,  
     Foster City, CA, USA 
Changes in mRNA levels of specific genes were quantified by Real time quantitative PCR. 
To validate the amount and quality of source of RNA, transcript levels of a housekeeping 
gene β -actin were measured. 
Primer and TaqMan probe sequences were chosen with assistance of software Primer 
Express version 1.0. Accession Numbers for sequences used were M16228 for GAP-43, 
NM_017009 for GFAP, NM_012673 for Thy-1, NM_012548 for ET-1, X57764 for ETB-
1, and NM_031144 for β -actin.  
 
2.3.7.3. TaqMan Primer and Probe Design 
1) The Primer Express software designs primers with a melting temperature (Tm) of 
58-60 oC, and probes with a Tm value of 10 oC higher. The Tm of both primers 
should be equal. 
2) Primers should be 15-30 bases in length. 
3)  The G+C content should ideally be 30-80%.  
4) The run of an identical nucleotide should be avoided. This is especially true for G, 
where runs of four or more Gs are not allowed. 
5) The total number of Gs and Cs in the last five nucleotides at the 3' end of the 
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primer should not exceed two. This helps to introduce relative instability to the 3' 
end of primers to reduce non-specific priming.  
6) Maximum amplicon size should not exceed 400 bp (ideally 50-150 bases). Smaller 
amplicons give more consistent results because PCR is more efficient and more 
tolerant of reaction conditions. 
7) The probes should not have runs of identical nucleotides (especially four or more 
consecutive Gs), G+C content should be 30-80%, there should be more Cs than Gs, 
and not a G at the 5' end.  
 
2.3.7.4. Primers 
GAP-43 primers  
 forward, 5’-CCGAGGCTGACCAAGAACA-3’,  
 used at 300nmol;  
 reverse, 5’-TGAGAAAGGGCAGGAGAGACA-3’,  
 used at 300nmol. 
  Product 88bp. 
GFAP primers  
 forward, 5’-TCAGTGCGGAGTCTCATGGA-3’,  
 used at 300nmol; 
 reverse, 5’-GTCCTCCCCTCCTGATTGC-3’,  
 used at 300nmol. 
 product 86bp. 
Thy-1 primers 
 forward, 5’-TGACAGCCTGCCTGGTGAA-3’,  
 used at 300nmol; 
 reverse, 5’-TCATGCTGGATGGGCAAGT-3’,  
 used at 300nmol. 
 product 78bp. 
β-actin primers 
 forward, 5’-GGAAATCGTGCGTGACATTAAAG-3’,  
 used at 300nmol; 
 reverse, 5’-CGGCAGTGGCCATCTCTT-3’,  
 used at 300nmol. 
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 product 73bp. 
ET-1 Primers 
 forward, 5’-AAGAGAGGTTGAGGTGTTCCCTAA-3’,  
 used at 300nmol; 
 reverse, 5’-CATCCCCAGACAGCAAGAAGA-3’,  
 used at 300nmol. 
ETB-1 Primers 
 forward, 5’- GCACTTCAGCACGGCTCTTAA-3’,  
 used at 300nmol; 
reverse, 5’- ACCCCTGAATAGAGTTTGAGTTCTTG-3’,  
used at 300nmol. 
 
2.3.7.5. TaqMan Probes 
TaqMan probes were labeled at the 5’-end with the reporter dye 6- FAM (6-
carboxyfluorescein; emission λmax=518 nm) and at the 3’-end with the quencher dye 
TAMRA (6-carboxytetramethylrhodamine; emission  λmax=582 nm).  
The following sequences were used as probes:  
GAP-43 5’ (FAM)-TTTCCACGTTGCCCCCACCTGAA-(TAMRA)-3’,  
 used as 200nmol/l. 
GFAP 5’ (FAM)- CTGCATCTCCAACTAACAGGATACCACC-(TAMRA)-3’,  
 used as 200nmol/l. 
Thy-1 5’ (FAM)- ACCTTCGACTGGACTGCCGTCATGA-(TAMRA)-3’,  
 used as 200nmol/l. 
β -actin 5’ (FAM)- AGCTGTGCTATGTTGCCCTAGACTTCGAGC-(TAMRA)-3’,  
 used as 200nmol/l. 
ET-1 5’ (FAM)- CTTCGTTTGCATCCGCTGGTAGCAA-(TAMRA)-3’,  
 used as 200nmol/l. 
ETB-1 5’ (FAM)- CCTCACTGCACTCTCAGCCCACTTACATTTAA-(TAMRA)-3’,  
 used as 200nmol/l. 
 
2.3.7.6. PCR Amplification 
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Component   Volume/Reaction Final Concentration  
Master Mix (2X)    12.5µl   1X 
Forward primer (100pmol/µl)   1.5µl   300nM 
Reverse primer (100pmol/µl)   1.5µl   300nM 
TaqMan Probe (100pmol/µl)   0.5µl   200nM 
RNase- free water    8µl 
Template RNA    1µl        
Total volume    25.0µl  
 
Real-Time Reverse-Transcriptase-Polymerase Chain Reaction (RT-PCR)  
Oligonucleotide sequences corresponding to the selected gene transcripts examined by RT-
PCR were designed using Primer Express software and are available on request from the 
author. One µg of total cellular RNA from the retinal tissue specimens was subjected to 
reverse transcription using M-MLV reverse Transcriptase and oligo-dT, following the 
manufacturer’s protocol (as described above). After first strand synthesis, an equivalent of 
50 ng of starting total cellular RNA (1/20th of the cDNA reaction) was added to three 
triplicate PCR reactions containing 1x TaqMan Universal PCR Master Mix, 300nmol/L 
forward primer, and 300nmol/L reverse primer in a final volume of 25 µl. The Universal 
master mix contains ROX (6-carboxy-X-rhodamine), the passive reference fluorochrome 
that normalizes for pipetting volume errors. Each reaction was performed in triplicate in 
96-well Optical reaction plates that cycled at 2 min at 50 oC, 95°C for 10 minutes, followed 
by 40 cycles of 95°C for 30 seconds, and 60°C for 1 minute on a GeneAmp 5700 sequence 
detection system. Fluorescent data were converted into cycle threshold (Cт) measurements 
using the 5700-system software and exported to Microsoft Excel. Before this analysis, the 
performance of each primer pair was tested by making a reference RNA cocktail 
containing RNA from all samples analyzed. One µg of this cocktail was converted to 
cDNA and a series of twofold serial dilutions were subjected to quantitative PCR analysis 
as described above. Plots of log (input cDNA) versus CT were examined to verify 
linearity. 
Each assay included ``no template´´ control and standard curve. 
 
2.3.7.7. Quantify the Amount of Template 
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2.3.7.7.1. Methods 
There are three methods to quantify the amount of template: 
1) Absolute standard method: In this method, a known amount of standard such as in 
vitro translated RNA (cRNA) is used. 
2) Relative standard: Known amounts of the target nucleic acid are included in the 
assay design in each run. 
3) Comparative Cт method: This method uses no known amount of standard but 
compares the relative amount of the target sequence to any of the reference values 
chosen and the result is given as relative to the reference value (such as the 
expression level of resting lymphocytes or a standard cell line). 
 
2.3.7.7.2. The Comparative Cт Method (∆∆ Cт) 
The comparative Cт method (∆∆ Cт) for relative quantitation of gene expression: 
This method enables relative quantitation of template and increases sample throughput by 
eliminating the need for standard curves when looking at expression levels relative to an 
active reference control (normalizer). For this method to be successful, the dynamic range 
of both the target and reference should be similar. A sensitive method to control this is to 
look at how ∆ Cт (the difference between the two Cт values of two PCRs for the same 
initial template amount) varies with template dilution. If the efficiencies of the two 
amplicons are approximately equal, the plot of log input amount versus ∆ Cт will have a 
nearly horizontal line (a slope of <0.10). This means that both PCRs perform equally 
efficiently across the range of initial template amounts. If the plot shows unequal 
efficiency, the standard curve method should be used for quantitation of gene expression. 
The dynamic range should be determined for both (1) minimum and maximum 
concentrations of the targets for which the results are accurate and (2) minimum and 
maximum ratios of two gene quantities for which the results are accurate. In conventional 
competitive RT-PCR, the dynamic range is limited to a target-to-competitor ratio of about 
10:1 to 1:10 (the best accuracy is obtained for 1:1 ratio). The real-time PCR is able to 
achieve a much wider dynamic range. 
As long as the target and normalizer have similar dynamic ranges, the comparative Cт 
method (∆∆ Cт method) is the most practical method. It is expected that the normalizer 
will have a higher expression level than the target (thus, a smaller Cт value). The 
calculations for the quantitation start with getting the difference (∆ Cт) between the Cт 
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values of the target and the normalizer: 
∆ Cт = Cт (target) - Cт (normalizer) 
This value is calculated for each sample to be quantitated (unless, the target is expressed at 
a higher level than the normalizer, this should be a positive value. It is no harm if it is 
negative). One of these samples should be chosen as the reference (baseline) for each 
comparison to be made. The comparative ∆∆ Cт calculation involves finding the 
difference between each sample's ∆ Cт and the baseline's ∆ Cт. If the baseline value is 
representing the minimum level of expression, the ∆∆ Cт values are expected to be 
negative (because the ∆ Cт for the baseline sample will be the largest as it will have the 
greatest Cт value). If the expression is increased in some samples and decreased in others, 
the ∆∆ Cт values will be a mixture of negative and positive ones. The last step in 
quantitation is to transform these values to absolute values. The formula for this is: 
 
Comparative expression level = 2 - ∆∆ Cт 
This study designed an untreated control group animal to modify the gene change of the 
experimental groups. Relative quantification methods were used to describe the change in 
expression of the target gene relative to an untreated control group at time zero in a time-
course study. The 2-∆∆Cт methods were used to calculate relative changes in gene 
expression determined from real-time quantitative PCR experiments. The ∆∆ Cт method 
was used to calculate fold expression levels relative to the average value of normal control 
RNA specimens (the calibrator). Expression of each gene in each sample was normalized to 
the signal obtained for a β -actin control performed on the same plate. Fold expression change 
for each sample was defined as 2 - ∆∆ Cт where ∆∆ Cт was defined as the difference between the 
sample’s ∆ Cт (Cтgene-Cт β -actin) and the average normal control reference’s ∆ Cт (Cтgene-Cт β -
actin).  
 
2.3.7.8. Standard Curve 
Performance of primer pairs and probes was tested using a series of twofold serial dilutions of 
a cocktail containing cDNA from all samples analyzed (equivalent of 1 µg total RNA). Plots of 
log (input cDNA) versus Cт were examined to verify amplification linearity. Slopes of the 
standard curves were also determined to assess amplification efficiency. The Cт values were 
plotted versus the log of the initial amount of cDNA to give the standard curve shown in 
Figure 1. Each sample and standard is done in triplicate. 
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2.3.7.9. Amplification Plot 
An amplification plot is the plot of fluorescence signal versus cycle number. In the initial 
of PCR, there is little change in fluorescence signal. This defines the baseline for the 
amplification plot. An increase in fluorescence above the baseline indicates the detection 
of accumulated PCR product. A fixed fluorescence threshold can be set above the baseline. 
The parameter Cт is defined as the fractional cycle number at which the fluorescence passes 
the fixed threshold. Figure 2 shows amplification plots of β –actin, GFAP, GAP-43, Thy-1, 
ET-1 and ETB genes. 
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Figure 1. Standard curves. Concentrations of cDNA are plotted against treshold cycles (Cт). 
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Figure 2. Representative amplification plots for β – actin, GFAP, GAP-43, Thy-1, ET-1 and 
ETB from retinal cDNA showing the increase in fluorescence signal (RN, y axis) with 
increasing cycle number (x-axis). The threshold (Cт) for signal detection was set at a RN 
of 0.02. 
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3. Results 
 
3.1. Immunohistochemistry 
Cryostat sections were examined from representative specimens to detect changes of 
protein expression. 
 
3.1.1. GFAP 
As expected, GFAP was confined to the astrocytes within the ganglion cell layer (GCL) 
and the nerve fibre layer (NFL) (Fig. 2F). Axotomized retinas showed a clear upregulation 
of GFAP at 5 and 14 days after axotomy (Fig. 2 A, B). GFAP-immunoreactive astrocytic 
cells and their processes were mainly observed in the NFL, GCL and inner plexiform layer 
(IPL) (Fig. 2 A, B). The immunostaining in the inner nuclear layer (INL), outer plexiform 
layer (OPL) and outer nuclear layer (ONL) (Fig. 2 A, B) was confined to Müller cells and 
their processes (arrowheads). Some GFAP-immunoreactive cells and processes could be 
observed to span through all retinal layers, including the outer segment of the ONL, and 
some processes extended even up to the photoreceptor layer (PRL). Compared to the 
injured retinas, grafted and regenerating retinas expressed lower levels of GFAP that was 
virtually restricted to the astrocytes with the Müller cells to show no upregulation at 5, 14 
and 21 days after grafting (Fig. 2 C-E). The data consistently show that degeneration of 
RGCs imposes higher expression of GFAP compared to partially degenerating and 
regenerating RGCs as occurred in the grafting paradigm. 
 
3.1.2. GAP-43 
The phosphoprotein GAP-43 has been shown to play a critical role during development of 
the CNS. In the retina of rats, GAP-43 is expressed in RGCs during development and 
postnatal. Then the protein is downregulated to disappear in adulthood. Indeed, staining of 
control and axotomized sections revealed virtually no positive immunoreactivity shown in 
GCL (Fig. 4 A, B and F). On the other hand, grafting of SN piece resulted in clear 
upregulation of GAP-43 in GCL at 5 days (Fig. 4 C, arrowhead). And GAP-43 
immunoreactivity was strongly upregulated in 14 days post grafting (Fig. 4 D, arrowhead). 
After 21 days, only few GAP-43 were expressed on GCL (Fig. 4 E). These were indicating 
that regenerating RGCs express GAP-43. 
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3.1.3.  NF-κb 
The transcriptional factor NF-κb seems to be a universal heterodimer, which is utilized to 
control histones by translocation from the cytosol into the nucleus of cell. Within the 
nervous system NF-κb plays a pivotal role and may exert functions associated with axonal 
growth. Indeed, while in normal retinas NF-κb is located within the cytoplasm (Fig. 5 F) it 
migrates into the nucleus 5 days after axotomy (Fig. 5 A), and then disappear obviously 
due to the death of the RGCs. In the regenerating retinas NF-κb is migrating into 
nucleolus-like structures.  
 
3.1.4. HSP27 
Heat shock proteins, first identified in Drosophila and later in almost all organisms, are 
indicators of cellular stress. HSP27 has been characterized in injured nerve cells including 
neurons in the retina. Imminohistochemically, HSP27 is expressed in RGCs in normal 
retinas (Fig. 6 F). The protein seems redistributed within the RGCs 5 days after cut of the 
optic nerve (Fig. 6 A). By 14 days after cut of the optic nerve when the retina is almost 
depleted of RGCs, no HSP27 is detected in the ganglion cell layer (Fig. 6 B). In grafted 
retinas, HSP27 is continually expressed up to 21 days postsurgery indicating that 
regenerating RGCs continue to express the molecule over long periods of time (Fig. 6 C-
E). 
 
3.1.5. Rhodopsin  
As expected, no changes in the rhodopsin expression were monitored after axotomy or 
grafting. This indicates that manipulations at the level of the optic nerve do not obviously 
influence the outer layers of the retina as seen in the content of Rhodopsin. Rhodopsin 
served therefore as the invariable parameter throughout the different groups and times 
postsurgery. 
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Figure 3. Expression of GFAP in axotomized (A, B), grafted (C-E), and control (F) retinas, 
(G) DAPI nuclear stain (blue signal). 
Abbreviation: GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear 
layer; ONL: outer nuclear layer; PRL: photoreceptor layer. 
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Figure 4. Photomicrographs of GAP-43 immunostaining in axotomized (A, B), grafted (C-
E), and control (F) retinas of rats. GAP-43 immunoreactivity in the ganglion cell fibre 
layer (C and D arrowhead). 
Abbreviation: GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear 
layer; ONL: outer nuclear layer. 
 
 
A B 
C D 
E F 
GCL 
IPL 
INL 
ONL 
  
-39- 
 
  
  
  
 
Figure 5. A, B) Expression of NF-κb within the GCL of axotomized retinas at 5 (A) and 
14 (B) days after optic nerve cut. Arrows point to the localization of the staining. C, D, E) 
Regenerating RGCs at 5 (C), 14 (D) and 21 (E) days after grafting express the molecule 
which is translocated into the nucleus (arrowheads). 
Abbreviation: GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear 
layer; ONL: outer nuclear layer. 
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Figure 6. Expression of HSP27 in axotomized retinas 5 (A) and 14 days (B) after 
axotomized. The disappearence of HSP27 is (B) points to the degeneration of RGCs. In 
contrast, regenerating retinas at 5 (C), 14 (D) and 21 (E) days express HSP27, although the 
number of cells is lower, due to the degeneration of most RGCs despite of regeneration. F) 
Control retina. Abbreviation: GCL: ganglion cell layer; IPL: inner plexiform layer; INL: 
inner nuclear layer; ONL: outer nuclear layer. 
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Figure 7. Immunohistochemical detection of Rhodopsin. The photoreceptor specific 
molecule is expressed in similar amounts throughout the period of axotomy (Fig. A, B) and 
regeneration (Fig. C-E). Control retina (Fig. F). 
Abbreviation: GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear 
layer; ONL: outer nuclear layer; PRL: photoreceptor layer. 
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3.2. RT-PCR  
Changes in mRNA levels were first estimated by semi-quantitative RT-PCR. Rhodopsin 
and β-actin mRNA levels were used to normalize the amount of retinal cDNA synthesized. 
We have detected changes in mRNA levels of thirteen genes in rat retinas by RT-PCR after 
optic nerve transected and grafted. These include growth-associated protein GAP-43; 
neuron specific marker Thy-1; glial fibrillary acidic protein GFAP; endothelin; stress-
response genes (HSP27 and HO-1); transcription factors (NF-κB, Stat3 and Stat6); 
glutamate transporters (EAAC-1); and calcium-binding protein (parvalbumin, 
Ca2+/Calmodulin). 
Since conventional RT-PCR detects the amount of final amplified product, from the results 
of those genes, no obvious changes (Fig. 8) were observed.   
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Figure 8.  Estimation of mRNA level for several genes in total retina after grafted and 
axotomized using semi-quantitative RT-PCR. Expression of β-actin was used as an internal 
control of RNA amount in each sample. C as normal control; A5, A14 as axotomized 5 and  
14 days; G5, G14 and G21 as grafted 5, 14, and 21 days. 
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3.3. Real time PCR 
 
3.3.1. Statistical Comparisons  
All in vivo experiments were repeated three times. And all values given in the text and 
figures are expressed as means ±SEM, with an indicating the number of observations. 
Statistical analysis was done by ANOVA followed by post-hoc testing using the LSD test 
(Statistica, Statsoft Inc., Tulsa OK). Significance was considered at p<0.05. 
 
3.3.2. Results of the experiment 
 
3.3.2.1. GFAP 
After 5 days, retinal expression of GFAP was significantly increased as compared to 
controls in both axotomized and grafted animals (p<0.01 vs. controls). However, GFAP 
expression did not differ significantly between grafted and axotomized animals at any 
time-point (Fig. 9). 
 
 
 
Figure 9. Retinal expression of GFAP in axotomized and grafted animals over time. Data 
are expressed as percentage of control. Mean±sem; n=3. ** p<0.01 
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3.3.2.2. GAP-43 
After 5 days, retinal expression of GAP-43 was significantly increased as compared to 
controls in grafted animals (146±11%, p<0.05), whereas no such increase was observed in 
the axotomized group (108±31%, p<0.05 vs. grafted animals). At later time-points, GAP-
43 expression was significantly decreased as compared to controls in both treatment groups 
(p<0.05). This decrease was less pronounced in grafted animals, but in contrast to day 5, 
differences did not reach statistical significance (day 14: 64±12% vs. 39±4%, p=0.14; day 
21: 46±6% vs. 42±1%, p=0.84).  
 
 
Figure 10. Retinal expression of GAP-43 in axotomized and grafted animals over time. 
Data are expressed as percentage of control. Mean±sem; n=3. * p<0.05 
 
3.3.2.3. Thy-1 
Retinal Thy-1 expression was found to be significantly decreased as compared to controls 
at all time-points, (p<0.01). Thy-1 expression did not differ significantly between grafted 
and axotomized animals (Fig.11). 
 
 
 
 
0%
100%
200%
Day 5 Day 14 Day 21
G
AP
-4
3 
m
RN
A 
(%
 C
on
tro
l) Axotomy 
Graft ∗# 
∗ 
∗ 
  
-46- 
 
Figure 11. Retinal expression of Thy-1 in axotomized and grafted animals over time. Data 
are expressed as percentage of control. Mean±sem; n=3. ** p<0.01 
 
3.3.2.4. ET-1 
Increases in retinal ET-1 expression over time appeared to be less pronounced in grafted 
animals as compared to axotomized animals (Day 14: 108±24% vs. 148±21%). However, 
differences in retinal ET-1 expression over time or between groups failed to reach 
statistical significance (ANOVA: p=0.20) (Fig. 12). 
 
3.3.2.5. ETB 
No significant changes of retinal ETB receptor expression were observed over time or 
between groups (ANOVA: p=0.81) (Fig. 13). 
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Figure 12. Retinal expression of ET-1 in axotomized and grafted animals over time. Data 
are expressed as percentage of control. Mean±sem; n=3.  
 
 
Figure 13. Retinal expression of ETB in axotomized and grafted animals over time. Data 
are expressed as percentage of control. Mean±sem; n=3.  
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4. Discussion 
 
4.1. Upregulation of GFAP Expression 
 
4.1.1. Reactive Hypertrophy of Astrocytes 
GFAP is a sensitive marker to monitor astrocytic responses to various injuries, including 
axotomy. As we can see from immunohistochemistry, axotomized retinas showed a clear 
upregulation of GFAP at 5 and 14 days post surgery. GFAP-immunoreactive astrocytes 
and their processes were mainly observed in the NFL and GCL. On the other hand, 
compared to the injured retinas, GFAP-immunoreactive astrocytes in grafted and 
regenerating retinas showed upregulated expression at 5, 14 days post surgery, and 
returned to control level 21 days after grafting. In addition, at mRNA level from 
quantitative real time PCR showed after 5 days, that retinal expression of GFAP was 
significantly increased as compared to controls in both axotomized and grafted animals 
(p<0.01 vs. controls). However, GFAP expression did not differ significantly between 
grafted and axotomized animals at any time-point. 
In the normal retina, astrocytes are reported to perform many other functions such as 
wrapping around ganglion cell axons, contacting other glial cells (e.g. Müller cells) to form 
adherent junctions and also playing a role in potassium buffering and in neuronal 
signalling [104].One conspicuous phenotypic change occurring in astrocytes during 
maturation and activation is the major increase seen in the synthesis of intermediate 
filament proteins, especially GFAP [47, 46, 28]. This major alteration in maturing 
astrocytes, directly associated with morphological changes, raises the possibility of their 
role in the functional shift from neurite-promoting to neurite-inhibiting elements, 
something that is still unknown. The two paradigms reported here are consistent with the 
fact that astrocytes are actively involved in the posttraumatic retinal repair.  
Recent findings indicate that astrocytes play a more expansive role in brain physiology 
than previously considered. In culture, astrocytes enhance synaptic efficacy, increase the 
number of functional neuronal synapses, and are necessary for the maintenance of neuronal 
synaptic stability [213]. Astrocytes are critical for neuronal survival [30] and contribute 
significantly to the maintenance of ion concentrations and clearance of glutamate from the 
synaptic cleft [166, 218]. Astrocytes express diverse neurotransmitter receptors and their 
activation increase intracellular free calcium [217]. 
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The expanding base of knowledge regarding astrocyte function in normal brain physiology 
suggests that astrocytes may play an important role in retina pathophsiology associated 
with optic nerve injury. 
Astrocytes play a significant role in normal neuron function, including active neuronal-glia 
signaling and maintenance of homeostasis in the extracellular microenvironment. Reactive 
astrocytosis represents hypertrophy and hyperplasia of astrocytes in response to CNS 
injuries. Early impairment of astrocyte function or early loss after optic nerve transection 
may compromise critical neuronal-glia interactions and thus may play a significant role in 
outcome after injury. 
 
4.1.2. Active Müller Cells of Axotomized Retina 
While astrocytes are located in the inner surface at the GCL, Müller cells have long 
processes spanning from the inner retina to the outer limiting membrane and support 
retinal structures lying in-between. Our results showed that immunostainined Müller cells 
and their processes in the INL, OPL and ONL. Some cells and processes could be observed 
to span throughout all retinal layers, including the outer segment of the ONL. After the 
optic nerve was transected, both types of glial cells become reactive and upregulated 
GFAP. Compared to the injured retinas, GFAP-immunoreactive Müller cells were not seen 
in grafted and regenerating retinas throughout all time point. This is an intriguing finding 
pointing to a sophisticated response of Müller cells, which seem to discern between 
degenerating and regenerating RGCs. 
GFAP and vimentin form intermediate filaments, a part of the cytoskeleton, in astrocytes 
and Müller cells; the production of intermediate filaments increases in reactive astrocytes 
and Müller cells under pathological conditions and after transplantation in the brain and the 
retina [7]. Increased production of intermediate filaments is reportedly associated with the 
formation of glial scarring that obstructs axonal growth [151, 125]). 
The Müller cells, which do not express significant amounts of GFAP in normal retina, have 
been shown to induce or upregulate their GFAP expression following a wide variety of 
pathological states in the retina including age-related retinal degeneration [36], retinal 
ischemia [106], inherited retinal dystrophy [177], retinal hyperoxia [152], induced retinal 
degeneration [45], glaucoma [209] and diabetes [113]. Thus, GFAP-positive staining has 
been demonstrated to be reliable indicator of most if not all acute and chronic neuroretinal 
pathology. 
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The results of the present experiments supported the proposal that Müller cells may play a 
role in the cell degeneration after axotomy. The increased glial cells may be activated to 
clear the neuron degeneration products [150]. Those were thought to recognize a variety of 
neuronal signals and actively control levels of K+, H+ and neurotransmitters such as 
glutamate in the extracellular space of the retina [137]. The immunoreactivities of Müller 
cells indicate that glial cells are activated by the changes in retinal environment linked to 
the neuronal degeneration in the axotomized retina. 
 
4.1.3. The Role of Glial Scar in Degenerating and Regenerating Retina 
It has been suggested that glial scarring after neural injury obstructs axonal regrowth by 
forming physical and diffusion barriers that separate the intact regions of the retina and 
CNS from the damaged area [51].Glial scarring by reactive astrocytes may also occur and 
is thought to be an attempt by the CNS to restore homeostasis after injury by isolating the 
damaged region [53]. Glial scarring may have other beneficial effects since astrocytes 
contribute to the removal of excitotoxins such as glutamate, restore and maintain the ionic 
environment, and provide neurotrophic support [134]. However, glial scarring has often 
been regarded as detrimental since it may interfere with subsequent neural repair or axonal 
regeneration [172], impede regeneration [167], and contribute to the development of 
seizures. The failure of axonal regeneration in the mammalian CNS is current attributed to 
the glial environment of the lesion site, which elaborates a multitude of inhibitory factors. 
The glial scars within the retina do not account for direct inhibition of axonal regowth 
because the optic nerve axons are cut behind the eye cup, and therefore, axonal stumps do 
not hit on potentially inhibiting astrocytic scars. 
Recent studies suggest that astrocytes may be severely damaged and lost following CNS 
injury prior to the development of reactive gliosis [116].The role of astrocytes in uptake of 
glutamate may have particular importance to the traumatically injured brain where large 
fluxes of extracellular glutamate [50, 96] likely contribute to acute excitotoxic processes 
[145, 77]. Specifically, early impairment of astrocyte function after optic nerve injury may 
compromise maintenance of homeostasis in the extracellular microenvironment and disrupt 
critical neuronal-glia interactions. Damage to or loss of astrocytes has important 
implications for neuronal survival and brain function. 
Astrocytes are the most numerous types of glia cells and provide many important functions 
to support neurons, including exchange of metabolic and nutritional material, maintenance 
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of ion concentrations, and clearance neurotransmitters in the vicinity of neurons [218]. 
Astrocytes have historically been viewed as nonexcitable structural support cells of the 
brain that maintain a healthy environment and provide trophic factors for neurons. The 
view of the role of astrocytes has expanded considerably due to recent observations of their 
participation in neuronal signalling [219, 220]. 
The majority of studies examining astrocytes after neuronal injury have focused on 
astrocytic activation characterized by enhanced expression of GFAP and glial scarring. 
Indeed, the CNS responds within days to injury by producing reactive astrogliosis or glial 
scarring [125]. Although not completely understood, glial scarring is thought to be a 
response by the CNS to restore homeostasis by isolating the damaged region [53]. 
However, the glial scar may interfere with any subsequent neural repair or axonal 
regeneration [172]. 
 
4.1.4. Grafting may Inhibit Astroglial Hypertrophy and Induce Functional Changes, 
Beneficial for Retina Regeneration 
Our data revealed a significant increase in GFAP immunoreactive after axotomy, and a 
limited immunoreactivity in the transplant group. In addition, in the transplant group, the 
reaction was confined to an astrocytic reaction induced by lesion, and was not shown in 
Müller cells. This shows that although both types of cells may regulate their GFAP content 
under certain circumstances, they respond differentially to a certain lesion.  
Recently several study have been undertaken to determine whether an imposed decrease in 
GFAP synthesis would affect neurite outgrowth. In a neuron-astrocyte coculture under 
experimental conditions in which astrogliosis has been elicited by a mechanical lesion 
[232], using antisense GFAP mRNA  have been observed that phenotypic changes, 
consecutive to the decrease in GFAP synthesis, induced a functional shift to neurite-
promoting elements [231]. Inhibition of GFAP synthesis leading to a reduction of 
astroglial hypertrophy relieves the blockade of neuritic outgrowth that normally is 
observed after a lesion [109].  
These results show that inhibition in GFAP synthesis, leading to a reduction of astroglial 
hypertrophy, relieves the blockade of neuritic outgrowth that normally is observed after a 
lesion. The mechanisms may involve changes in the secretion of extracellular matrix 
molecules by astrocytes. 
Our findings suggest that astrocytes are particularly vulnerable to nerve injury and that 
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damage to their integrity may compromise critical glia-neuron interactions. Such a 
disturbance would disrupt the maintenance of homeostasis in the extracellular environment 
and likely contribute to subsequent neuronal damage. 
 
Briefly, the mechanisms, which involved in the retina regeneration after optic nerve 
grafting remain poorly understood. The reactive gliosis, which occurs after an injury to the 
CNS and leads to the glial scar, has been considered as one of the major impediments to 
neurite outgrowth and axonal regeneration. A glial scar consists mainly of reactive, 
hypertrophic astrocytes. These reactive cells acquire new properties, leading to a non-
permissive support for neurons. Astrogial reactivity is mainly characterized by a high 
overexpression of the major component of the gliofilaments, GFAP. This GFAP 
overexpression is related to the astroglial morphological response to injury. Based our data 
from immunohistochemistry, less GFAP expression on grafted retina indicate that 
regenerating retina may modulate of GFAP synthesis, reversing the hypertrophic 
phenotype, might also reverse the blockage of neuritic outgrowth observed after a lesion. 
Although our quantitative real-time PCR did not show significantly mRNA level change, 
the mean of GFAP message level were lower in grafting group compare to those 
axotomized groups as could see. Especially at later time points of 14 and 21 days showed 
obviously different. Those changes fit protein level change nicely. The statistical analysis 
failed to differ both group may due to the data variable and the small amount of animals of 
this experiment. Or it may due to message RNA changed earlier then protein, our time 
course fail to catch it. For further experiment, Western blot may be used for measuring the 
protein level changes. 
 
4.2. GAP-43 Upregulation in Regenerated Retina 
In mature mammals, RGCs are unable to regrow injured axons and soon undergo apoptotic 
death. These well known events are a paradigm of regenerative failure in the CNS and may 
mimic pathophysiological sequelae that underlie degenerative diseases. The failure to 
regenerate spontaneously has been attributed to downregulation of growth associated 
proteins, and in particular of GAP-43. However, as shown before, RGCs can regenerate 
their axons in vivo through a peripheral nerve graft, and an average about 15-17% RGCs 
survive and regrow their axons [211].  
The phosphoprotein GAP-43 has been shown to play a critical role during development of 
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the CNS. In the retina of rats, GAP-43 is expressed in RGCs during development and 
postnatal. Then the protein is downregulated to disappear in adulthood. Because RGCs 
only express GAP-43 during axon outgrowth, probes for this protein enable to visualize 
RGCs in a growth state [127, 133, 37, 182, 16]. Developmentally, RGCs express this 
protein during axon outgrowth and synaptic refinement, then downregulate it as their 
connections mature [196]. Normally, GAP-43 is transiently upregulated after axotomy and 
declines as RGCs undergo atrophic changes [37]. Levels remain high only if regeneration 
is sustained [197, 12, 37, 16]. 
As expected, intact normal retina showed no staining at all in our experiment. Axotomized 
sections revealed RGCs unstained. On the other hand, grafting of SN piece resulted in clear 
upregulation of GAP-43 in GCL at 5 days. A dramatic increase in the immunostaining of 
RGCs was seen with in the overlying fiber layer at 14 days. GAP-43 could no longer be 
detected at 21 days. These were indicating that regenerating RGCs expressed GAP-43. 
Increase GAP-43 expression in grafted retina also be conformed in mRNA level by using 
quantitative real time PCR. As the data show, a transient upregulation of GAP-43 was seen 
in grafted animals, whereas no such increase was observed in the axotomized group. At 
later time-points (14 and 21 days), GAP-43 expression was significantly decreased as 
compared to controls in both treatment groups. This result is a line of evidence that GAP-
43 upregulation is causally connected with regenerative growth, although the mechanism 
of GAP-43 involvement remains elusive. 
 
4.2.1. Role in Neural Development and Structural Plasticity 
Convergent evidence from many labs indicates that GAP-43 plays a key role in guiding the 
growth of axons and modulating the formation of new connection. One clear indication of 
this comes from a recent study in transgenic mice, overexpression of GAP-43 leads to the 
spontaneous formation of new synapses and enhanced sprouting after injury. Thus, even in 
the absence of additional trophic factors, GAP-43 enables neurons to sprout new terminals, 
and can therefore be considered an intrinsic determinant of the neuron’s growth state [4]. 
Primary sensory neurons from embryonic chick, when grown on poly-L-lysine, failed to 
extend axons when treated with antisense oligonucleotides complementary to portions of 
GAP-43 mRNA [2]. 
GAP-43 in axon elongation in embryonic cells and its decline during maturation has been 
correlated with the loss of regenerative ability within the CNS. According to data from 
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various models, GAP-43 may work via modulation of signaling cascades rather than 
autonomously causing growth [52]. This result has generally been interpreted as showing 
that, although these neurons are intrinsically capable of regenerating their axons, this can 
only occur outside the inhibitory influences that normally prevail in the CNS. 
 
4.2.2. Correlation of regenerative axonal growth with GAP-43 
GAP-43 was expressed within the RGCs along regenerating retina. Former studies showed 
GAP-43 as a crucial role in regenerative growth. Identification of GAP-43 in growth cone 
membranes [198, 235]) and its involvement in optic tract formation [13, 234, 205, 206] 
revealed that this protein is associated with neurite growth in general, but also with 
synaptic plasticity.  
It has been postulated that the neuronal growth associated protein GAP-43 plays an 
essential role in axon elongation. Although termination of developmental axon growth is 
generally accompanied by a decline in expression of GAP-43, a subpopulation of dorsal 
root ganglion (DRG) neurons retains constitutive expression of GAP-43 throughout 
adulthood. Peripheral nerve regeneration occurring subsequent to injury of the peripheral 
axon branches of adult DRG neurons is accompanied by renewed elevation of GAP-43 
expression. Lesions of DRG central axon branches in the dorsal roots are also followed by 
some regenerative growth, but little or no increase in GAP-43 expression above the 
constitutive level is observed. 
How does axonal growth correlate with GAP-43 upregulation? From previous it was 
shown that first axons enter a SN graft 5 days after surgery [221].This is in agreement with 
our finding that GAP-43 content increases at 5 days. Maximum numbers of axons were 
observed in regenerating retinas at around 14 days after grafting by addition of newly 
formed growth cones between day 5 and day 14 [212]. This is in line with the present 
finding that GAP-43 shows its peak expression at 14 days after surgery. The down 
regulation of GAP-43 observed at 21 days indicates that regenerative growth is declining at 
this stage. Indeed, in blind-ending SN grafts as used in this study, no additional axons are 
growing within the graft at this stage and some decline in the numbers of axons may be 
observed [212] depending on the length of the SN graft. This strong correlation between 
the different stages of regeneration and the GAP-43 expression is proving that the 
molecule plays a crucial role as assumed by the former studies [189]. 
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4.3. NF-κB may play a Neuroprotective Role in the Early Response to Regenerated 
RGCs 
NF-κB is a transcription factor, which is activated by various stimuli. Activated NF-κB 
plays a protective role from the cell death in the injured ganglion cells [27]. NF-κB plays a 
role in cell death as a pro- or anti-apoptotic transcription factor. It has been hypothesized 
that NF-κB is activated to transcribe the essential genes for cell death or survival [131]. 
Within the nervous system NF-κB plays a pivotal role and may exert functions associated 
with axonal growth.  
Since the translocation of NF-κB from the cytoplasm to the nucleus is essential for NF-κB 
activation, we examined its activation with immunohistochemistary. Indeed, while in 
normal retinas NF-κB is located within the cytoplasm, it translocated into the nuclei of 
RGCs in regenerating retinas. 
The immunohistochemical data clearly showed that a greater amount of NF-κB was 
observed in the nucleus than in the cytoplasm of the grafted retina. NF-κB expression was 
upregulated 5 days after both axotomized and grafted retina. A dramatically increase could 
be seen at 14 days after grafting with the immunostaining to disappear at 14 days after 
axotomy, perhaps due to the death of the RGCs. In the regenerating retinas, NF-κB 
migrated into the nucleus to aggregate within nucleolus-like structures. These results 
confirm that the positively stained NF-κB in immunohistochemistry is due to the activation 
and translocation from the cytoplasm to the nucleus. This specific pattern of molecular 
movement suggested that NF-κB may play a neuroprotective role in the early response to 
regenerated RGCs. The mechanism of how NF-kB functions in regenerating retina remains 
to be elucidated.  
NF-κB influences the expression of a complex array of genes in the nervous system and, in 
general, the genes serve important functions in cellular responses to injury and in neuronal 
plasticity. Genes encoding several different injury-responsive cytokines are induced by 
NF-κB in glia and neurons. In the developing rat nervous system, levels of NF-κB activity 
change, with levels peaking in the cerebellum during the early postnatal period at a time 
when synaptogenesis is occurring [186]. A peptide inhibitor of NF-κB (SN50) blocks the 
ability of nerve growth factor (NGF) to prevent death of cultured sympathetic neurons 
[120], suggesting a role for NF-κB in the control of neuronal death during development of 
the nervous system. The presence of NF-κB in synaptic terminals located at considerable 
distances from the neuronal cell body, and its ability to be activated locally at those sites, 
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strongly suggest that this transcription factor modulates synaptic function [146]. 
Finally, NF-κB may play an important role in the apoptotic death of neurons that occurs 
during normal development of the nervous system. Such natural neuronal death is thought 
to be regulated by electrical activity in neurons and by competition of neurons for a limited 
supply of neurotrophic factors produced by target cells upon which synapses form. 
Injury to the brain or spinal cord induces a cascade of signaling events that stimulate NF-
κB activation in injured neurons and in injury responsive glial cells. Cellular and molecular 
analyses of brain and spinal cord tissues in experimental rodent models of stroke, epileptic 
seizures, and traumatic injury have begun to reveal the complex functions of NF-κB in 
modifying neuronal degeneration and recovery. 
It has become clear that NF-κB influences the neurodegenerative process by directly 
affecting gene expression in neurons themselves and by indirectly regulating gene 
expression in glial cells. Data from studies of mice lacking the p50 subunit of NF-κB 
suggest that, overall, NF-κB activation enhances ischemic neuronal death [187], but its 
effects differ between cell types such that, whereas activation of NF-κB in microglia 
promotes ischemic neuronal degeneration, activation of NF-κB in neurons may increase 
their survival after a stroke. Cell culture studies have clearly shown that activation of NF-
κB in neurons protects them against excitotoxic and metabolic insults relevant to the 
pathogenesis of stroke, including glucose deprivation and exposure to glutamate [25, 233]. 
Levels of NF-κB activity are increased in cerebral cortex within hours of traumatic brain 
injury in rats, after which they remain elevated for at least 24 hours. Within neurons in the 
injured cortex, levels of p65 immunoreactivity increase first in the axons and subsequently 
in neuronal cell bodies [142]. Neighboring microglia and astrocytes also show increased 
levels of p65. This increase in immunoreactivity persists for many months, particularly in 
the margins of the progressively enlarging ventricle, suggesting a role for NF-κB in a 
prolonged inflammatory process. 
The emerging data described above suggest that NF-κB plays important roles in cellular 
responses to injury of the nervous system in both acute and chronic neurodegenerative 
conditions. Proteins involved in NF-κB signaling are therefore potentially important targets 
for therapeutic intervention in an array of neurological disorders. In general it appears that 
activation of NF-κB in neurons protects them against degeneration, whereas activation of 
NF-κB in microglia promotes neuronal degeneration. 
The latter studies have shown that the neuroprotective effect of dietary restriction involves 
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induction of a mild stress response that results in increased production of heat-shock 
proteins. 
 
4.4. HSP27 
Heat shock proteins, first identified in Drosophila and later in almost all organisms, are 
indicators of cellular stress. HSP27 has been characterized in injured nerve cells including 
neurons in the retina. These data were confirmed in the present study by showing HSP27 in 
the ganglion cells layer of normal retinas. The protein seems redistributed 5 days after the 
optic nerve transection. By 14 days after transected nerve when the retina is almost deleted 
of RGCs, no HSP27 is detected in the ganglion cell layer. In grafted retinas, HSP27 is 
continually expressed up to 21 days postsurgery indicating that regenerating ganglion cell 
layer continues expressing the molecule over long periods of time. However, the 
immunohistochemical data show a less consistent staining, which needs to be further 
approved. In addition, it is not clear from the images whether RGCs or astrocytes within 
the ganglion cell layer account for the positive staining.  
HSP27 were found to be overexpressed in some areas of the brain under simulated 
pathological conditions [97, 98, 157, 158, 87] as well as in the pathological conditions of 
serious brain diseases, such as Alexander's disease, Alzheimer's disease, and Parkinson's 
disease [89, 194, 169]. Of particular interest is the fact that HSPs are easily induced in 
astrocytes, which are relatively injury resistant (Soltesz, 1996) and therefore have often 
been used for in vitro experiments designed to investigate the mechanisms of their 
induction [135, 78, 121, 183]. A recent study [10] showed that this stress-induced protein 
was simultaneously induced in Bergmann glial cells, a specialized astrocyte, in rat brain 
and were then transported into the radial fibres, which project into the synaptic-enriched 
molecular layer of the cerebellum. Thus, the induction of HSP27 in the astrocytes of CNS 
appears to be common under certain stress-related conditions, and the induction 
mechanism remained to be determined. 
Crush-injured rat sciatic nerves induction of HSP27 was examined using the combined 
technique of immunofluorescent labelling and confocal laser scanning microscopy 
(CLSM), followed by electron microscopy (EM) and immunoelectron microscopy (IEM). 
In this study demonstrated that the induction of HSP27 is specific to the Schwann cells 
(SCs) columns, which are known to guide axonal sprouts during the regeneration of 
nerves, and their associated axons. SCs were already known to show dramatic functional 
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and morphological alterations during the process of Wallerian degeneration and the 
ensuing regeneration after axotomy [73, 81].Thus, a strong induction of HSP27 can be 
detected in a certain phase of SCs that have been transformed by axotomy. Moreover, the 
induction of HSP27 was accompanied by the re-expression of the intermediate filament 
protein, one of the cytoskeletal components of SCs, so the HSP27 play a role in 
modulating the cytoskeletal dynamics of SCs during the regeneration of the peripheral 
nerves [82]. 
Experimental evidence suggests that the brain responds to injury in a regionally 
heterogeneous manner and that the stress response is differentially regulated among cell 
types in the CNS [181, 192]. Increased expression of heat shock proteins (HSPs) has been 
observed in CNS following ischemia, trauma, hyperthermia and exposure to neurotoxins 
[20, 144, 214]. The presence of HSPs in astrocytes in vitro and in vivo supports the idea 
reported by Sharp et al. [192] that glial cells have a functional role in brain injury. 
 
4.5. Thy-1 and ET-1 
In the CNS, Thy-1 is expressed predominantly on neurons and serves as a specific marker 
for neurons. In the eye, Thy-1 is found predominantly in the GCL. From our data of 
quantitative real time PCR, retinal Thy-1 mRNA expression was significantly decreased as 
compared to controls at all time-points (p<0.01). And Thy-1 expression did not differ 
significantly between grafted and axotomized animals. This may be explained by the low 
abundance of RGCs within the retina as they make up less than 1% of all cells. 
Quantitative changes in ganglion cell specific genes are therefore limited, because one 
starts with non-specific RNA prepared from the entire retina. In addition, even in the 
regenerating retina, only 15 to 20% of ganglion cells survive and regenerate, therefore 
further limiting the chance to detect differences between regenerating and degenerating 
retinas. Thy-1 may be an extremely sensitive marker for isolated RGCs, because,in spite of 
neuroprotection and accessibility of the attached PN graft, most of the ganglion cells 
(between 80-85%) die progressively after axotomy therefore further diluting the percentage 
of RGCs within retinal tissue [211].  
Since ETB were expressed by astrocytes and regulate astrocytes hypertrophy in crush 
injured CNS [175], we detected both ET-1 and ET-B mRNA level. The results appeared 
less specific to detect differences between de- and regenerating retinas. ET-1 and ETB both 
molecules are expressed in capillary endothelial cells, which show less exit in both 
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degenerating and regenerating retina. So we consider both molecules as controls in 
addition to glial and neuronal markers. They may change their patterns of expression in 
long-term experiments utilising retinas, which survive months after surgery, in order to 
examine advanced gliosis connected with neovascularization. 
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5. Summary 
Molecular Characterization of the Regenerating Retinal Ganglion Cells 
using Quantitative PCR and Immunohistochemistry 
 
The aim of this study was to detect whether neuronal, glial and endothelial markers change 
their expression patterns after transection of the optic nerve in adult rats and after the 
transect axons gain the opportunity to regrow within an autologous graft of sciatic nerve. 
The ability of the adult mammalian central nervous system and the retina to regenerate 
following injury is influenced by a balanced activity between factors that promote, and of 
those that inhibit neuronal survival, regeneration, and sprouting. It was found by 
immunohistochemistry that the properties of the injured ganglion cells affect the extent of 
neuronal survival and regeneration by showing specific expression of neuron-specific 
markers like GAP-43 and Thy-1. On the other hand, glial cells at the site of injury are also 
critically involved in determining the regenerative outcome as shown by detecting specific 
regulation of glial markers like GFAP. To gain further insights into the molecular 
mechanisms responsible for regeneration of retina, the semi-quantitative RT-PCR and real 
time PCR was performed for differential gene expression in the retina. A comparison of 
mRNAs in those retinas receiving sciatic nerve grafts with those in axotomized retinas and 
untreated retinas was conducted. At various times elapsed after injury, glial cell markers, 
neuronal markers and endothelin were analysed. The data confirmed the 
immunohistochemical studies and revealed specific regulation of GAP-43 and GFAP, but 
no specific patterns for Thy-1, ET-1 and ETB, as expected from their cellular expression 
patterns. In spite of the high sensitivity of the model used in the present study and in the 
reliability of the methods, the molecular mechanisms underlying neuronal degeneration, 
repair and regeneration after axon injury have yet to be identified.  
It is therefore of crucial importance to characterize the different populations of cells which 
may codetermine whether regeneration will take placing or not. 
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6. Zusammenfassung 
Molekulare Charakterisierung der regenerierenden retinalen 
Ganglienzellen mittels quantitativer PCR und Immunhistochemie 
 
Das Ziel dieser Untersuchung war es, zu erfassen, ob neuronale, gliale und endotheliale 
Marker nach einer Durchtrennung des Sehnervs der adulten Ratte und nachdem die 
durchtrennten Axone die Möglichkeit erhalten, innerhalb eines autologen Transplantates 
aus dem Ischiasnerven zu wachsen, ihre Expressionsmuster verändern. Die Fähigkeit des 
adulten Säuger-ZNS und der Retina, nach einer Verletzung zu regenerieren, wird durch 
eine ausgewogene Aktivität zwischen wachstumsfördernden und hemmenden Faktoren 
beeinflusst. Mittels Immunhistochemie wurde gefunden, dass die Eigenschaften der 
verletzten Ganglienzellen das Ausmaß des neuronalen Überlebens und die Regeneration 
beeinflussen: Es konnte gezeigt werden, dass neuron-spezifische Marker wie GAP-43 und 
Thy-1 reguliert exprimiert wurden. Auf der anderen Seite, waren auch gliale Zellen an der 
Verletzungsseite am Ausgang der Regeneration involviert, was durch die Erfassung einer 
spezifischen Regulation glialer Marker wie GFAP gezeigt werden konnte. Um weitere 
Einblicke in die molekularen Mechanismen der retinalen Regeneration zu erhalten, wurde 
eine semi-quantitative RT-PCR und eine Echtzeit-PCR für die differentielle Genexpression 
durchgeführt. Es wurde ein Vergleich von mRNAs aus Retinae mit Nerventransplantat, 
solcher aus axotomierten Retinae und aus unbehandelten Kontrollen durchgeführt. Zu 
verschiedenen Zeiten nach der Verletzung wurden gliale, neuronale und endotheliale 
Marker analysiert. Die Daten bestätigten die immunhistochemischen Befunde und zeigten 
eine spezifische Regulation von GAP-43 und GFAP, nicht aber von Thy-1, ET-1 und ETB, 
was aus ihrer zellulären Expression erwartet wurde. Trotz der hohen Sensitivität des 
benutzten Modells und der Reliabilität der Methoden sind die molekularen Mechanismen 
der neuronalen Degeneration, der Reparatur und der Regeneration nach axonaler 
Verletzung noch zu analysieren. Es ist deshalb von großer Bedeutung, verschiedene 
Populationen von Zellen zu charakterisieren, die darüber mitbestimmen, ob Regeneration 
stattfindet oder nicht.  
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8. Abbreviations 
ATP    adenosine triphosphate 
CLSM    confocal laser scanning microscopy  
CNS    cental nervous system 
Cт    threshold  
∆∆ Cт    the comparative Cт method  
DAPI   4’, 6-diamidino-2-phenylindol 
DRG    dorsal root ganglion  
EM    electron microscopy 
ET-1   endothelin-1 
ETA   endothelin A receptor 
ETB   endothelin B receptor 
FCS    fetal calf serum  
GAP-43   growth associated protein-43 
GFAP   glial fibrillary acidic protein 
GCL   ganglion cell layer 
HSPs   heat shock proteins 
Hsp27   heat shock protein 27 
Hsp32   heat shock protein 32 
IEM    immunoelectron microscopy 
Ig    immunoglobulin 
INL    inner nuclear layer 
IPL   inner plexiform layer 
IPLs   inner plexiform layers 
MAP              mitogen-activated protein  
MMLV-RT   moloney murine leukaemia virus reverse transcriptase 
NF-κB   nuclear factor kappa B 
NFL   nerve fibre layer 
NGF    nerve growth factor  
ON    optic nerve   
ONL    outer nuclear layer 
OPL    outer plexiform layer 
PNS   peripheral nervous system  
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PRL   photoreceptor layer 
RGC       retinal ganglion cells 
SCs   Schwann cells 
SN   sciatic nerve 
Tm    melting temperature 
TNF-α   tumor necrosis factor alpha 
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